| |
|
|
|
Alpine Immune Sciences Inc.  
|
|
5.01 -0.3 (-0.06%) |
10-19 16:00 |
|
Open: |
5.29 |
Pre close: |
5.31 |
Target:
|
7.08
|
|
High: |
5.29 |
Low: |
5.01 |
Resistance:
|
6.06
6.79
|
|
Volume: |
11,091 |
Market Cap: |
69M |
Support:
|
4.89
4.07
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.15
 |
MACD |
MACD(12,26):
|
-0.35  |
|
MA(20): |
5.70 |
Signal(12,26,9): |
-0.31 |
|
MA(100): |
7.09 |
Stochastic Oscillator |
%K(14,3):
|
13.79 |
|
MA(250): |
8.60 |
%D(3): |
15.39 |
|
Average Volume(K) |
3-Month: |
2021
|
52-Week |
High:
|
11.75 |
|
10-Days: |
2617 |
Low: |
4.89 |
|
RSI |
RSI(14):
|
33.08 |
Change(%): |
-55.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.470 |
Return on Equity (ttm) |
-27.1 |
Shares Out. (M) |
13.85 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-24.9 |
Shares Float (M) |
13.68 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
-47.2 |
% Held by Institutions |
66.30 |
|
Forward EPS |
-2.604 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
57 |
|
Book Value (p.s.) |
1.040 |
EBITDA (p.s.) |
0.163 |
P/E |
-3.41 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.82 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.17 |
P/S |
991264320.00 |
|
Operating Margin |
-2282.93 |
Levered Free Cash Flow
(M) |
-14.44 |
P/CF |
-3.13 |
|
|
|
|
|
|
